Evidence map›Paper›PMID 25228319›Full record

ReviewCirculation. Heart failure2014

Danon disease: clinical features, evaluation, and management.

Ryan S D'souza, Cecilia Levandowski, Dobromir Slavov, Sharon L Graw, Larry A Allen, Eric Adler, Luisa Mestroni, Matthew R G Taylor

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Circulation. Heart failure, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 96 papers.

0numbers the graph read from it
0cells of the map it votes in
96citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

96 citing papers in PubMed.

  1. Review
  2. Article
  3. Cardiac characteristics of Chinese patients with Danon disease associated withInternational journal of cardiology. Heart & vasculature · 2026
    Article
  4. Review
  5. Review
  6. Article
  7. Autophagy-lysosomal pathway in neurodegeneration.Molecular neurodegeneration advances · 2026
    Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

36 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ryan S D'souzaFrom the Adult Medical Genetics Program and Division of Cardiology, University of Colorado, Denver (R.S.D., C.L., D.S., S.L.G., L.A.A., L.M., M.R.G.T.); and Division of Cardiology, University of California, San Diego (E.A.).
Cecilia LevandowskiFrom the Adult Medical Genetics Program and Division of Cardiology, University of Colorado, Denver (R.S.D., C.L., D.S., S.L.G., L.A.A., L.M., M.R.G.T.); and Division of Cardiology, University of California, San Diego (E.A.).
Dobromir SlavovFrom the Adult Medical Genetics Program and Division of Cardiology, University of Colorado, Denver (R.S.D., C.L., D.S., S.L.G., L.A.A., L.M., M.R.G.T.); and Division of Cardiology, University of California, San Diego (E.A.).
Sharon L GrawFrom the Adult Medical Genetics Program and Division of Cardiology, University of Colorado, Denver (R.S.D., C.L., D.S., S.L.G., L.A.A., L.M., M.R.G.T.); and Division of Cardiology, University of California, San Diego (E.A.).
Larry A AllenFrom the Adult Medical Genetics Program and Division of Cardiology, University of Colorado, Denver (R.S.D., C.L., D.S., S.L.G., L.A.A., L.M., M.R.G.T.); and Division of Cardiology, University of California, San Diego (E.A.).
Eric AdlerFrom the Adult Medical Genetics Program and Division of Cardiology, University of Colorado, Denver (R.S.D., C.L., D.S., S.L.G., L.A.A., L.M., M.R.G.T.); and Division of Cardiology, University of California, San Diego (E.A.).
Luisa MestroniFrom the Adult Medical Genetics Program and Division of Cardiology, University of Colorado, Denver (R.S.D., C.L., D.S., S.L.G., L.A.A., L.M., M.R.G.T.); and Division of Cardiology, University of California, San Diego (E.A.).
Matthew R G TaylorFrom the Adult Medical Genetics Program and Division of Cardiology, University of Colorado, Denver (R.S.D., C.L., D.S., S.L.G., L.A.A., L.M., M.R.G.T.); and Division of Cardiology, University of California, San Diego (E.A.). matthew.taylor@ucdenver.edu.

Funding

Colorado Clinical and Translational Sciences InstituteUL1TR001082 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2013 to 2017
$48.0M
Medical Scientist Training ProgramT32GM008497 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI WILSON, CARA C. · 1993 to 2022
$15.2M
Whole genome DNA sequencing to identify novel genes in dilated cardiomyopathyR01HL109209 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI TAYLOR, MATTHEW R · 2012 to 2016
$2.1M
Cardiomyocyte phenotype and mechanotransduction in Filamin C gene variants causing arrhythmogenic cardiomyopathyR01HL147064 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI MESTRONI, LUISA, TAYLOR, MATTHEW R · 2020 to 2023
$2.1M
NCATS NIH HHS UL1 TR001082NHLBI NIH HHS 1R01HL109209-01A1NHLBI NIH HHS R01 HL109209NHLBI NIH HHS R01 HL147064NIGMS NIH HHS T32 GM008497
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Disease ManagementGlycogen Storage Disease Type IIbDNADNA Mutational AnalysisGenetic Predisposition to DiseaseGlobal HealthHumansLysosomal-Associated Membrane Protein 2MorbidityMutationDNALAMP2 protein, humanLysosomal-Associated Membrane Protein 2cardiomyopathy, dilatedcardiomyopathy, hypertrophicgeneticsglycogen storage disease type IIblysosomal-associated membrane protein 2molecular biologymutation

Identifiers

PMID25228319
PMCPMC4169002

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.